Drug Trial Radar · NCT06564142
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
605
Actual
Start
Aug 30, 2024
Primary completion
Jan 30, 2028
Study completion Jan 30, 2028
Sponsor
- Lead sponsor
- Alpine Immune Sciences Inc, A Subsidiary of VertexIndustry
- Sponsor type
- Industry
- First posted
- Aug 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserving renal function.
Conditions
- Immunoglobulin A Nephropathy
Interventions
PovetaciceptDrug
Subcutaneous injection administration.
Placebo (matched to Povetacicept)Drug
Placebo matched to Povetacicept subcutaneous injection administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in 24-hour Urine Protein to Creatinine Ratio (uPCR) at Week 36Time frame: From Baseline at Week 36
- Total Estimated Glomerular Filtration Rate (eGFR) Slope Through Week 104Time frame: From Baseline Through Week 104
Locations
318 sites in 33 countries. Site status is shown where the registry gives one.
Apogee Clinical Research, LLC
Huntsville, Alabama
Arizona Kidney Disease and Hypertension Center - Thomas Office
Phoenix, Arizona
Arizona Kidney Disease and Hypertension Center - Tuscon
Tucson, Arizona
West Coast Kidney
Fremont, California
The Medical Research Group, Inc. (FRENOVA)
Fresno, California
CARE Institute - Carabello Kidney
Los Angeles, California
Providence Medical Foundation - Orange
Orange, California
National Nephrology Alliance Research
Riverside, California
UC Davis Health
Sacramento, California
Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California
University of California San Francisco (UCSF)
San Francisco, California
Western Nephrology
Arvada, Colorado
Colorado Kidney Care
Denver, Colorado
Nephrology Associates Delaware Kidney (FRENOVA)
Newark, Delaware
South Florida Nephrology Group PA, Research Div.
Coral Springs, Florida
Dolphin Medical Research
Doral, Florida
Nephrology Associates of Central Florida
Hollywood, Florida
Tectum Medical Research, LLC
Hollywood, Florida
South Florida Research Institute
Lauderdale Lakes, Florida
Florida Kidney Physicians - Melbourne
Melbourne, Florida
Med-Care Research
Miami, Florida
Professional Research Center
Miami, Florida
Nephrology Associates of South Miami
Miami, Florida
On Health Research Center
Miami, Florida
Combined Research Orlando Phase I-IV
Orlando, Florida
BioResearch Partner
Pembroke Pines, Florida
D&H Pompano Research Center
Pompano Beach, Florida
Cordova Research Institute, LLC
Sweetwater, Florida
SciMerge Clinical Research
Atlanta, Georgia
Georgia Nephrology - Lawrenceville
Lawrenceville, Georgia
Randomize Now - Midtown
Newnan, Georgia
Care Institute - Chubbuck, ID
Chubbuck, Idaho
Care Institute - Idaho Falls
Idaho Falls, Idaho
CARE - Boise Kidney Institute
Meridian, Idaho
Bioluminux Clinical Research
Naperville, Illinois
Rockford Nephrology Associates
Rockford, Illinois
Nephrology Associates of Northern Illinois and Indiana (NANI)
Indianapolis, Indiana
Nephrology Physicians LLC
Mishawaka, Indiana
Nephrology Associates of Kentuckiana
Louisville, Kentucky
Renal Associates of Baton Rouge
Baton Rouge, Louisiana
Showing 40 of 318 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.